文献速递其他结缔组织病

干燥综合征自然病程及进展预测因素:SICCA注册研究

Natural History and Predictors of Progression to Sjögren's Syndrome Among Participants of the Sjögren's International Collaborative Clinical Alliance Registry.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2018-01-03

基于SICCA注册中771例完成2–3年随访的参与者,评估干燥综合征(SS)表型特征与SS状态的变化。采用2012 ACR标准时93%的SS患者随访仍符合标准,采用2016 ACR/EULAR标准时为89%;基线未符合标准者分别有9%和8%进展为SS。基线高丙种球蛋白血症和低补体血症分别使按ACR标准进展为SS的风险增加4倍和6倍。

要点

  • 已诊断SS者2–3年内状态稳定,93%(ACR)和89%(ACR/EULAR)仍符合标准。
  • 基线未符合标准者中9%(ACR)和8%(ACR/EULAR)随访进展为SS。
  • 基线高丙种球蛋白血症和低补体血症预测进展为SS。

核心结论

  • SS的表型特征和SS状态在2–3年内总体稳定,但基线高丙种球蛋白血症和低补体血症可预测进展为SS。

研究设计与样本

  • SICCA注册队列研究,纳入有唾液功能低下、干眼、唇腺灶性淋巴细胞性涎腺炎或抗SSA/SSB抗体任一客观指标的参与者,在基线检查后2–3年召回重复临床检查和标本采集。
  • 截至2013年9月15日,SICCA注册共3514例入组,3310例符合条件,771例完成随访 visit。

主要发现

  • 基线符合2012 ACR标准的SS患者中,93%在2–3年后仍符合该标准;基线符合2016 ACR/EULAR标准的SS患者中,89%随访仍符合。
  • 基线不符合ACR标准者中9%随访进展并符合ACR标准;基线不符合ACR/EULAR标准者中8%随访进展并符合ACR/EULAR标准。
  • 基线高丙种球蛋白血症者按ACR标准进展为SS的可能性是无该特征者的4倍(95%CI 1.5–10.1)。
  • 基线低补体血症者按ACR标准进展为SS的可能性是无该特征者的6倍(95%CI 1.8–20.4)。

关键数值与推荐

  • 采用2012 ACR分类标准和2016 ACR/EULAR分类标准判定SS状态及进展。
  • 基线高丙种球蛋白血症进展为SS的OR为4(95%CI 1.5–10.1),低补体血症的OR为6(95%CI 1.8–20.4)。

临床怎么用

  • 对基线未达SS分类标准但存在高丙种球蛋白血症或低补体血症者,应加强随访监测以识别进展为SS的可能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To explore changes in the phenotypic features of Sjögren's syndrome (SS), and in SS status among participants in the Sjögren's International Collaborative Clinical Alliance (SICCA) registry over a 2-3-year interval. METHODS: All participants in the SICCA registry who were found to have any objective measures of salivary hypofunction, dry eye, focal lymphocytic sialadenitis in minor salivary gland biopsy, or anti-SSA/SSB antibodies were recalled over a window of 2 to 3 years after their baseline examinations to repeat all clinical examinations and specimen collections to determine whether there was any change in phenotypic features and in SS status. RESULTS: As of September 15, 2013, a total of 3,514 participants had enrolled in SICCA, and among 3,310 eligible, 771 presented for a followup visit. Among participants found to have SS using the 2012 American College of Rheumatology (ACR) classification criteria, 93% again met the criteria after 2 to 3 years, and this proportion was 89% when using the 2016 ACR/European League Against Rheumatism (EULAR) criteria. Among those who did not meet ACR or ACR/EULAR criteria at baseline, 9% and 8%, respectively, had progressed and met them at followup. Those with hypergammaglobulinemia and hypocomplementemia at study entry were, respectively, 4 and 6 times more likely to progress to SS by ACR criteria than those without these characteristics (95% confidence interval 1.5-10.1 and 1.8-20.4, respectively). CONCLUSION: While there was stability over a 2-3-year period of both individual phenotypic features of SS and of SS status, hypergammaglobulinemia and hypocomplementemia at study entry were predictive of progression to SS.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Shiboski CH, Baer AN, Shiboski SC, et al. Natural History and Predictors of Progression to Sjögren's Syndrome Among Participants of the Sjögren's International Collaborative Clinical Alliance Registry. Arthritis Care Res (Hoboken). 2018. PMID: 28437595. doi:10.1002/acr.23264

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。